Slowly Expanding Lesions: A New Target for Progressive Multiple Sclerosis Trials?
Neurology
.
2022 Apr 26;98(17):699-700.
doi: 10.1212/WNL.0000000000200230.
Epub 2022 Mar 11.
Authors
Sarah B Simmons
1
,
Daniel Ontaneda
1
Affiliation
1
From the Mellen Center for Multiple Sclerosis, Cleveland Clinic, OH.
PMID:
35277445
DOI:
10.1212/WNL.0000000000200230
No abstract available
Publication types
Editorial
Comment
MeSH terms
Brain
Humans
Multiple Sclerosis* / drug therapy
Multiple Sclerosis, Chronic Progressive* / drug therapy